Rotech Healthcare Inc. (OTCBB: ROHI) announced the closing of its previously announced offering of $290 million in aggregate principal amount of Senior Second Lien Notes due 2018.
Rotech expects to use the net proceeds received from the offering to repay all of its Senior Subordinated Notes due 2012, for payment of related fees and expenses and for general corporate purposes, as applicable, including funding the company's strategic priorities.
The notes were offered only to qualified institutional buyers in reliance on Rule 144A, to persons outside the United States under Regulation S, under the Securities Act, and to certain accredited investors as defined in Rule 501(a) under the Securities Act of 1933, as amended. The initial issuance of the notes was not registered under the Securities Act, and the notes may not be offered or sold without registration in the United States except pursuant to an exemption from the registration requirements of the Securities Act and applicable state securities laws.
New center established to bridge AI technology and healthcare applications